The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation

Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: Age dependency and pharmacological interaction with steroids

(2011) Jorge R. Ferraris et al.   PEDIATRIC TRANSPLANTATION

Expression of CYP3A5 and P-glycoprotein in Renal Allografts With Histological Signs of Calcineurin Inhibitor Nephrotoxicity

(2011) Christoph Metalidis et al.   TRANSPLANTATION

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

(2010) Christine E. Staatz et al.   CLINICAL PHARMACOKINETICS

Dosing Tacrolimus Based on CYP3A5 Genotype: Will It Improve Clinical Outcome?

(2010) T van Gelder et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients

(2010) D R J Kuypers   CLINICAL PHARMACOLOGY & THERAPEUTICS

An Integrative Approach for Identifying a Metabolic Phenotype Predictive of Individualized Pharmacokinetics of Tacrolimus

(2010) P B Phapale et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

CYP3A5andABCB1polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation

(2010) Arnaud Capron et al.   PHARMACOGENOMICS

Update on the clinical pharmacogenomics of organ transplantation

(2010) Gilbert J Burckart et al.   PHARMACOGENOMICS

Understanding the Genetic Basis for Adverse Drug Effects: The Calcineurin Inhibitors

(2010) Jane P. F Bai et al.   PHARMACOTHERAPY

A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients

(2010) Arden Barry et al.   THERAPEUTIC DRUG MONITORING

Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients

(2009) Khaled Benkali et al.   CLINICAL PHARMACOKINETICS

Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients

(2009) W Zhao et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Higher tacrolimus trough levels on days 2-5 post-renal transplant are associated with reduced rates of acute rejection

(2009) C.M. O’Seaghdha et al.   CLINICAL TRANSPLANTATION

Individualizing Calcineurin Inhibitor Therapy in Renal Transplantation - Current Limitations and Perspectives

(2009) R. Press et al.   CURRENT PHARMACEUTICAL DESIGN

CYP3Apolymorphisms and immunosuppressive drugs in solid-organ transplantation

(2009) Jian Wang   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus

(2009) Sung-In Park et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant Recipients

(2009) Rogier R Press et al.   THERAPEUTIC DRUG MONITORING

Pharmacogenetics of Calcineurin Inhibitors in Renal Transplantation

(2009) Eliecer Coto et al.   TRANSPLANTATION

Clinical Impact of Polymorphisms of Transport Proteins and Enzymes Involved in the Metabolism of Immunosuppressive Drugs

(2009) C. Rosso Felipe et al.   TRANSPLANTATION PROCEEDINGS

Effect of CYP3A5 Genotype on Renal Allograft Recipients Treated With Tacrolimus

(2009) J.S. Chen et al.   TRANSPLANTATION PROCEEDINGS

Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction?

(2008) S. Lam et al.   ANNALS OF PHARMACOTHERAPY

Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation

(2008) Dela Golshayan et al.   TRANSPLANT IMMUNOLOGY

Pharmacogenetics in solid organ transplantation: current status and future directions

(2007) Hylke de Jonge et al.   Transplantation Reviews